These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6722780

  • 21. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone.
    Shiu RP, Paterson JA.
    Cancer Res; 1984 Mar; 44(3):1178-86. PubMed ID: 6692402
    [Abstract] [Full Text] [Related]

  • 22. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.
    Reddel RR, Murphy LC, Sutherland RL.
    Cancer Res; 1983 Oct; 43(10):4618-24. PubMed ID: 6883318
    [Abstract] [Full Text] [Related]

  • 23. Role of polyamines in estradiol-induced growth of human breast cancer cells.
    Lima G, Shiu RP.
    Cancer Res; 1985 Jun; 45(6):2466-70. PubMed ID: 3921243
    [Abstract] [Full Text] [Related]

  • 24. Effects of gossypol on the cell cycle phases in T-47D human breast cancer cells.
    Thomas M, von Hagen V, Moustafa Y, Montmasson MP, Monet JD.
    Anticancer Res; 1991 Jun; 11(4):1469-75. PubMed ID: 1746904
    [Abstract] [Full Text] [Related]

  • 25. Mode of estrogen action on cell proliferation in CAMA-1 cells: III. Effect of antiestrogen.
    Leung BS.
    Anticancer Res; 1987 Jun; 7(2):219-25. PubMed ID: 3592635
    [Abstract] [Full Text] [Related]

  • 26. Estradiol induction of retinoic acid receptors in human breast cancer cells.
    Roman SD, Ormandy CJ, Manning DL, Blamey RW, Nicholson RI, Sutherland RL, Clarke CL.
    Cancer Res; 1993 Dec 15; 53(24):5940-5. PubMed ID: 8261407
    [Abstract] [Full Text] [Related]

  • 27. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.
    Osborne CK, Boldt DH, Clark GM, Trent JM.
    Cancer Res; 1983 Aug 15; 43(8):3583-5. PubMed ID: 6861130
    [Abstract] [Full Text] [Related]

  • 28. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
    Lewis JS, Osipo C, Meeke K, Jordan VC.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 94(1-3):131-41. PubMed ID: 15862958
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ, Raney S.
    Cell Biol Int; 1998 Feb 15; 22(6):413-9. PubMed ID: 10328849
    [Abstract] [Full Text] [Related]

  • 31. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ, Zhu BT.
    J Steroid Biochem Mol Biol; 2004 Mar 15; 88(3):265-75. PubMed ID: 15120420
    [Abstract] [Full Text] [Related]

  • 32. DDT mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
    Dees C, Askari M, Foster JS, Ahamed S, Wimalasena J.
    Mol Carcinog; 1997 Feb 15; 18(2):107-14. PubMed ID: 9049186
    [Abstract] [Full Text] [Related]

  • 33. Response to estrogen by the human mammary carcinoma cell line CAMA-1.
    Leung BS, Qureshi S, Leung JS.
    Cancer Res; 1982 Dec 15; 42(12):5060-6. PubMed ID: 7139610
    [Abstract] [Full Text] [Related]

  • 34. Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells.
    Soto AM, Murai JT, Siiteri PK, Sonnenschein C.
    Cancer Res; 1986 May 15; 46(5):2271-5. PubMed ID: 3697972
    [Abstract] [Full Text] [Related]

  • 35. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD, Sun JZ, Bi DS, Ma R.
    Ai Zheng; 2003 Apr 15; 22(4):376-9. PubMed ID: 12703992
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice.
    Leung CK, Shiu RP.
    Cancer Res; 1981 Feb 15; 41(2):546-51. PubMed ID: 7448802
    [Abstract] [Full Text] [Related]

  • 39. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
    ter Haar E, Hamel E, Balachandran R, Day BW.
    Anticancer Res; 1997 Feb 15; 17(3C):1861-9. PubMed ID: 9216636
    [Abstract] [Full Text] [Related]

  • 40. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V, Venkiteswaran S, Nair SK, Verma A, Thomas TJ, Zhu BT, Thomas T.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.